Eunice Kim

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Positive Breast Cancer

Affordable Care Act

Sentinel Lymph Node

Vascular Endothelial Growth Factor

Top Venues

Clinical ophthalmology (Auckland, N.Z.)

Health affairs scholar

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Fariel LaMountain, Molly T Beinfeld, William Bruce Wong, Eunice Kim, James D Chambers
Biosimilar underutilization alone does not foretell a broken biologics market. Health affairs scholar 2 (7) (2024)
Glenn Yiu, Shilpa Gulati, Victoria S Higgins, Emily Coak, Daniel Mascia, Eunice Kim, Galin Spicer, David Tabano
Factors Involved in Anti-VEGF Treatment Decisions for Neovascular Age-Related Macular Degeneration: Insights from Real-World Clinical Practice. Clinical ophthalmology (Auckland, N.Z.) 18 (2024)
Glenn Yiu, Shilpa Gulati, Victoria S Higgins, Emily Coak, Daniel Mascia, Eunice Kim, Galin Spicer, David Tabano
Factors Involved in Anti-VEGF Treatment Decisions for Neovascular Age-Related Macular Degeneration: Insights from Real-World Clinical Practice. Clinical ophthalmology (Auckland, N.Z.) 18 (2024)
Fariel LaMountain, Molly T Beinfeld, William Bruce Wong, Eunice Kim, James D Chambers
Biosimilar underutilization alone does not foretell a broken biologics market. Health affairs scholar 2 (7) (2024)
Jesse A Sussell, David J Press, Svenn Alexander Kommandantvold, Eunice Kim, Yolande du Toit, Anita Fung
Impact of Pertuzumab and Ado-Trastuzumab Emtansine on Cumulative Avoidance of Recurrence Among Women Treated for Locally Advanced, Inflammatory, or Early-Stage Nonmetastatic HER2-Positive Breast Cancer in the United States. Advances in therapy (2023)